| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $241.5M | $252.2M | $251.4M |
| YoY Revenue Growth % | -4.2% | +0.3% | — |
| Gross Profit | $183.3M | $197.5M | — |
| Gross Margin % | 75.9% | 78.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$224.3M | -$710.8M | -$329.8M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$138.9M | -$413.1M | -$202.4M |
| EBITDA (Normalized) | -$210.9M | -$700.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $53.8M | $58.2M | $41.2M |
| Capital Expenditures (CapEx) | $16.7M | $12.3M | — |
| Free Cash Flow (FCF) | $37.1M | $45.9M | $41.2M |
| FCF Margin % | 15.3% | 18.2% | 16.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $163.6M | $105.4M | — |
| Total Debt (Short + Long Term) | $156.1M | $229.4M | — |
| Total Stockholders' Equity | $379.0M | $607.2M | — |